DDS development for drug life cycle management

Bibliographic Information

Other Title
  • 2010年問題の解決策を考える  医薬品のライフサイクルマネジメントとDDS開発
  • 医薬品のライフサイクルマネジメントとDDS開発
  • イヤクヒン ノ ライフサイクル マネジメント ト DDS カイハツ

Search this article

Abstract

The keyword, life cycle management(LCM)of medicines has recently attracted attention, because the patents of many blockbuster drugs will expire or have expired around 2010. There are many strategies for LCM, and drug delivery system(DDS)is one of the useful approaches. But, it seemed that the development of DDS medicines in Japan was a little bit difficult compared to that in US or Europe. There were many factors such as drug price system, safety tests of new additives, etc. The circumstances for DDS development in Japan have recently become much better through the political efforts of Japanese government.

Journal

  • Drug Delivery System

    Drug Delivery System 26 (2), 99-105, 2011

    THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM

Citations (1)*help

See more

References(16)*help

See more

Details 詳細情報について

Report a problem

Back to top